Journal of Clinical Immunology

, Volume 25, Issue 1, pp 29–40

TLR-9 Activation of Marginal Zone B Cells in Lupus Mice Regulates Immunity Through Increased IL-10 Production

  • Elizabeth H. Field


Bacterial DNA triggers B-cell proliferation and induces immunoglobulin secretion. Chromatin–IgG complexes activate autoreactive B cells by co-engaging B-cell receptor (BCR) and TLR-9, thus suggesting a role for innate signaling in systemic autoimmunity. Spleen cells from lupus prone Palmerston North (PN) mice produce several fold less IL-12p40 than controls in response to CpG–oligodeoxynucleotides (ODNs). Here we show that B cells are primarily responsible for this abnormality. The removal of B cells from PN cultures markedly increased IL-12p40. Moreover, the addition of purified B cells back to PN splenocyte cultures resulted in a B-cell number dependent/ IL-10-mediated suppression of IL-12p40. The B cells were the major source of IL-10. In response to CpG, B cells from several lupus strains produced twice as a much IL-10 as controls, but failed to produce IL-10 when stimulated through BCR or CD40. PN and control mice expressed IL-10R similarly, and the difference in IL-10 secretion remained when anti-IL-10R blocking antibodies were used. IFN-γ and IL-4 regulated CpG-induced IL-10 secretion in opposite directions. The abnormal IL-10 response in lupus mice was derived from B cells with the marginal zone phenotype, and could be downregulated with inhibitory ODNs. We hypothesize that TLR-9 activated lupus B cells can modulate T-cell mediated inflammatory responses through IL-10 production. Therefore, B cells may contribute to the lupus pathogenesis in many different ways: as antigen-presenting cells for self antigens, as effector cells for autoantibody production, and as IL-10 secreting regulatory cells.

CpG-islands interleukin-10 interleukin-12 lupus erythematosus systemic antigens marginal zone B cells 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Krieg AM: CpG DNA: A pathogenic factor in systemic lupus erythematosus. J Clin Immunol 15:284–292, 1995Google Scholar
  2. 2.
    Deng GM, Nilsson IM, Verdrengh M, Collins LV, Tarkowski A: Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 5:702–705, 1999Google Scholar
  3. 3.
    Klinman D: Does activation of the innate immune system contribute to the development of rheumatoid arthritis? Arthritis Rheum 48:590–593, 2003Google Scholar
  4. 4.
    Lenert P, Goeken A, Handwerger BS, Ashman RF: Innate immune responses in lupus-prone Palmerston North mice: Differential responses to LPS and bacterial DNA/CpG oligonucleotides. J Clin Immunol 23:202–213, 2003Google Scholar
  5. 5.
    Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 20:197–216, 2002CrossRefPubMedGoogle Scholar
  6. 6.
    Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdorfer B, Giese T, et al.: Quantitative expression of Toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligonucleotides. J Immunol 168:4531–4537, 2002.Google Scholar
  7. 7.
    Rhee SH, Hwang D: Murine Toll-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NFkB and expression of the inducible cyclooxygenase. J Biol Chem 275:34035–34040, 2000Google Scholar
  8. 8.
    Ogata H, Su I-H, Miyake K, Nagai Y, Akashi S, Mecklenbrauker I, et al.: The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 192:23–29, 2000Google Scholar
  9. 9.
    Messina JP, Gilkeson GS, Pisetsky DS: Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 147:1759–1764, 1991Google Scholar
  10. 10.
    Krieg AM, Yi A-K, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, et al.: CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546–549, 1995CrossRefPubMedGoogle Scholar
  11. 11.
    Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al.: A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745, 2000PubMedGoogle Scholar
  12. 12.
    Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel, M, et al.: Cutting edge: Role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167:3555–3558, 2001Google Scholar
  13. 13.
    Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, Akira S, et al.: Human TLR-9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc Natl Acad Sci USA 98:9237–9242, 2001Google Scholar
  14. 14.
    Massari P, Heneke P, Ho Y, Latz E, Golenbock DT, Wetzler LM: Cutting edge: Immune stimulation by neisserial porins is Toll-like receptor 2 and MyD88 dependent. J Immunol 168:1533–1537, 2002PubMedGoogle Scholar
  15. 15.
    Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al.: Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3:196–200, 2002Google Scholar
  16. 16.
    Yi AK, Krieg AM: Rapid induction of mitogen-activated protein kinases by immune stimulatory CpG DNA. J Immunol 161:4493–4497, 1998Google Scholar
  17. 17.
    Lenert P, Stunz L, Yi AK, Krieg AM, Ashman RF: CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-κ B activation. Antisense Nucleic Acid Drug Dev 11:247–256, 2001Google Scholar
  18. 18.
    Yi AK, Chang M, Peckham DW, Krieg AM, Ashman RF: CpG oligodeoxyribonucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry. J Immunol 160:5898–5906, 1998Google Scholar
  19. 19.
    Stunz LL, Lenert P, Peckham D, Yi A-K, Haxhinasto S, Chang M, et al.: Inhibitory oligonucleotides specifically block effects of stimulatory CpG oligonucleotides in B cells. Eur J Immunol 32:1212–1222, 2002Google Scholar
  20. 20.
    Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon γ. J Immunol 93:2879–2883, 1996Google Scholar
  21. 21.
    Yi AK, Hornbeck P, Lafrenz DE, Krieg AM: CpG DNA rescue of murine B lymphoma cells from anti-IgM-induced growth arrest and programmed cell death is associated with increased expression of c-myc and bcl-xl. J Immunol 157:4918–4925, 1996Google Scholar
  22. 22.
    Luzina IG, Knitzler RH, Atamas SP, Gause WC, Papadimitriou JC, Sztein MB, et al.: Vasculitis in the Palmerston North mouse model of lupus: Phenotype and cytokine production profile of infiltrating cells. Arthritis Rheum 42:561–568, 1999Google Scholar
  23. 23.
    Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157:1840–1845, 1996Google Scholar
  24. 24.
    Chase JH, Hooker NA, Mildenstein KL, Krieg AM, Cowdery JS: Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12. Clin Immunol Immunopathol 84:185–193, 1997Google Scholar
  25. 25.
    Snapper C, Paul W: Interferon-γ and B cell stimulatory factor-1 reciprocally regulate Ig isotype production. Science 236:944–947, 1987Google Scholar
  26. 26.
    Ozmen L, Roman D, Fountoulakis M, Schmidt R, Ryffel B, Garotta G: Experimental therapy of systemic lupus erythematosus: The treatment of NZB/NZW mice with mouse soluble interferon-g receptor inhibits the onset of glomerulonephritis. Eur J Immunol 25:6–12, 1995Google Scholar
  27. 27.
    Lenert P, Rasmussen W, Ashman RF, Ballas ZK: Structural characterization of the inhibitory DNA motif for the type A(D)-CpG-induced cytokine secretion and NK-cell lytic activity in mouse spleen cells. DNA Cell Biol 22:621–631, 2003Google Scholar
  28. 28.
    Gursel I, Gursel M, Yamada H, Ishii KJ, Takeshita F, Klinman DM: Repetitive elements in mammalian telomeres suppress bacterial DNA-induced immune activation. J Immunol 171:1393–1400, 2003Google Scholar
  29. 29.
    Krug A, Rothenfusser S, Hornung V, Jahrsdorfer B, Blackwell S, Ballas ZK, et al.: Identification of CpG oligonucleotide sequences with high induction of IFN-alpha/beta in plasmocytoid dendritic cells. Eur J Immunol 31:2154–2163, 2001Google Scholar
  30. 30.
    Verthelyi D, Ishii KJ, Gursel M, Takeshita F, Klinman DM: Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs. J Immunol 166:2372–2377, 2001Google Scholar
  31. 31.
    Chesnut RW, Grey HM: Studies on the capacity of B cells to serve as antigen-presenting cells. J Immunol 126:1075–1079, 1981Google Scholar
  32. 32.
    Lanzavecchia A: Antigen-specific interaction between T and B cells. Nature 314: 537–539, 1985Google Scholar
  33. 33.
    Fuchs EJ, Matzinger P: B cells turn off virgin but not memory T cells. Science 258:1156–1159, 1992Google Scholar
  34. 34.
    Constant S, Schweitzer N, West J, Ranney P, Bottomly K: B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo. J Immunol 155:3734–3741, 1995Google Scholar
  35. 35.
    Constant SL: B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J Immunol 162:5695–5703, 1999Google Scholar
  36. 36.
    Paroli M, Accapezzato D, Insalaco A, Plebani A, Balsano F, Barnaba V: Long-lasting memory-resting and memory-effector CD4+ T cells in human X-linked agammaglobulinemia. Blood 99:2131–2137, 2002Google Scholar
  37. 37.
    Epstein MM, Di Rosa F, Jankovic D, Sher A, Matzinger P: Successful T cell priming in B cell-deficient mice. J Exp Med 182:915–922, 1995Google Scholar
  38. 38.
    Bosio CM, Gardner D, Elkins KL: Infection of B cell-deficient mice with CDC 1551, a clinical isolate of Mycobacterium tuberculosis: Delay in dissemination and development of lung pathology. J Immunol 164:6417–6425, 2000Google Scholar
  39. 39.
    Graham MB, Braciale TJ: Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 186:2063–2068, 1997Google Scholar
  40. 40.
    Smelt SC, Cottereli SEJ, Engwarda CR, Kaye PM: B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology. J Immunol 164:3681–3688, 2000Google Scholar
  41. 41.
    Moulin V, Andris F, Thielemans K, Maliszewski C, Urbain J, Moser M: B lymphocytes regulate dendritic cell (DC) function in vivo: Increased interleukin 12 production by DCs from B cell-deficient mice results in T helper cell type 1 deviation. J Exp Med 192:475–482, 2000Google Scholar
  42. 42.
    Cunningham AF, Fallon PG, Khan M, Vacheron S, Acha-Orbea H, MacLennan ICM, et al.: Th2 activities induced during virgin T cell priming in the absence of IL-4, IL-13, and B cells. J Immunol 169: 2900–2906, 2002Google Scholar
  43. 43.
    Shen H, Whitmire JK, Fan X, Shedlock DJ, Kaech SM, Ahmed R: A specific role for B cells in the generation of CD8 T cell memory by recombinant Listeria monocytogenes. J Immunol 170:1443–1451, 2003Google Scholar
  44. 44.
    Linton PJ, Harbertson J, Bradley LM: A critical role for B cells in the development of memory CD4 cells. J Immunol 165:5558–5565, 2000Google Scholar
  45. 45.
    Tsitoura DC, Yeung VP, DeKuyff RH, Umetsu DT: Critical role of B cells in the development of T cell tolerance to aeroallergens. Int Immunol 14:659–667, 2002Google Scholar
  46. 46.
    Roth R, Gee RJ, Mamula MJ: B lymphocytes as autoantigen-presenting cells in the amplification of autoimmunity. Ann NY Acad Sci 815:88–104, 1997Google Scholar
  47. 47.
    Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 392:245–252, 1998CrossRefPubMedGoogle Scholar
  48. 48.
    Skok J, Poudrier J, Gray D: Dendritic cell-derived IL-12 promotes B cell induction of Th2 differentiation: A feedback regulation of Th1 development. J Immunol 163:4284–4291, 1999Google Scholar
  49. 49.
    Jankovic D, Cheever AW, Kullberg MC, Wynn TA, Yap G, Caspar P, et al.: CD4+ T cell-mediated granulomatous pathology in schistosomiasis is downregulated by a B cell-dependent mechanism requiring Fc receptor signaling. J Exp Med 187:619–629, 1998Google Scholar
  50. 50.
    Wolf SD, Dittel BN, Hardardottir F, Janeway CA Jr: Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 184:2271–2278, 1996Google Scholar
  51. 51.
    Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM: B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3:944–950, 2002Google Scholar
  52. 52.
    Vakkalanka RK, Woo C, Kirou KA, Koshy M, Berger D, Crow MK: Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera. Arthritis Rheum 42:871–881, 1999Google Scholar
  53. 53.
    Xu LG, Shu HB: TNFR-associated factor-3 is associated with BAFF-R and negatively regulates BAFF-R-mediated NF-kB activation and IL-10 production. J Immunol 169:6883–6889, 2002Google Scholar
  54. 54.
    Mackay F, Woodcock SA, Lawton AC, Baetscher M, Schneider P, Tschopp J, et al.: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 190:1697–1710, 1999Google Scholar
  55. 55.
    Yin Z, Bahtiyar GM, Zhang N, Liu L, Zhu P, Robert ME, et al.: IL-10 regulates murine lupus. J Immunol 169:2148–2155, 2002Google Scholar
  56. 56.
    Leadbetter EA, Rifkin AR, Hohlbaum AM, Beaudette BC, Schlomchik MJ, Marshak-Rothstein A: Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603–607, 2002Google Scholar
  57. 57.
    Gilkeson GS, Grudier JP, Karounos DG, Pisetsky DS: Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA. J Immunol 142:1482–1486, 1989Google Scholar
  58. 58.
    Chen Y, Lenert P, Weeratna R, McCluskie M, Wu T, Davis HL, et al.: Identification of methylated CpG motifs as inhibitors of the immune stimulatory CpG motifs. Gene Ther 8:1024–1032, 2001Google Scholar
  59. 59.
    Zeuner RA, Ishii KJ, Lizak MJ, Gursel I, Yamada H, Klinman DM, et al.: Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum 46:2219–2224, 2002Google Scholar
  60. 60.
    Matzinger P: The danger model: A renewed sense of self. Science 296:301–305, 2002CrossRefPubMedGoogle Scholar
  61. 61.
    Gilkeson GS, Ruiz P, Pippen AM, Alexander AL, Lefkowith JB, Pisetsky DS: Modulation of renal disease in autoimmune NZB/NZW mice by immunization with bacterial DNA. J Exp Med 183:1389–1397, 1996Google Scholar
  62. 62.
    Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, de Lema GP, et al.: Activation of Toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. FASEB J 18:534–536, 2004Google Scholar
  63. 63.
    Hasegawa K, Hayashi T: Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZBxNZW F1 mice. Lupus 12:838–845, 2003Google Scholar
  64. 64.
    Liu J, Beller DI: Aberrant production of IL-12 by macrophages from several autoimmune-prone mouse strains is characterized by intrinsic and unique patterns of NF-κ B expression and binding to the IL-12 p40 promoter. J Immunol 169:581–586, 2002Google Scholar
  65. 65.
    Liu J, Beller DI: Distinct pathways for NF-κ B regulation are associated with aberrant macrophage IL-12 production in lupus- and diabetes-prone mouse strains. J Immunol 170:4489–4496, 2003Google Scholar
  66. 66.
    Wither JE, Roy V, Brennan LA: Activated B cells express increased levels of costimulatory molecules in young autoimmune NZB and (NZBxNZW)F(1) mice. Clin Immunol 94:51–63, 2000Google Scholar
  67. 67.
    Martin, F, Kearney, JF: Marginal-zone B cells. Nat Rev Immunol 2:323–335, 2002CrossRefPubMedGoogle Scholar
  68. 68.
    Chen X, Martin F, Forbush KA, Perlmutter RM, Kearney JF: Evidence of selection of a population of multireactive B cells into the splenic marginal zone. Int Immunol 9:27–41, 1997Google Scholar
  69. 69.
    Kenny JJ, Rezanka LJ, Lustig A, Fischer RT, Yoder J, Marshall S, et al.: Autoreactive B cells escape clonal deletion by expressing multiple antigen receptors. J Immunol 164:4111–4119, 2000Google Scholar
  70. 70.
    Li Y, Li H, Weigert M: Autoreactive B cells in the marginal zones that express dual receptors. J Exp Med 195:181–188, 2002Google Scholar
  71. 71.
    Grimaldi CM, Michael DJ, Diamond B: Cutting Edge: Expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J Immunol 167:1886–1890, 2001Google Scholar
  72. 72.
    Atencio S, Amano H, Izui S, Kotzin BL: Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells. J Immunol 172: 4159–4166, 2004Google Scholar

Copyright information

© Springer Science + Business Media, Inc. 2005

Authors and Affiliations

    • 1
    • 3
    • 1
  • Elizabeth H. Field
    • 1
    • 2
    • 1
    • 2
  1. 1.Division of Rheumatology, Department of Internal MedicineCarver College of Medicine, The University of IowaIowa City
  2. 2.VA Medical CenterIowa City
  3. 3.Department of Internal MedicineThe University of IowaIowa City

Personalised recommendations